NLRP3 and cystic fibrosis: The group confirmed these observations in a murine CF model, noting that MCC950 inhibition of NLRP3 in vivo was associated with reduced lung IL-1β, reduced airway inflammation, and reduced duration of opportunistic Pseudomonas infection.